Mahamaya Lifesciences
add_icon

Mahamaya Lifesciences

174.20
-4.75
(-2.65%)
Market Cap
407.68 Cr
PE Ratio
25.35
Volume
25,200.00
Day High - Low
183.50 - 174.20
52W High-Low
205.05 - 111.00
ann
There are new updates from the company18 hrs ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
407.68 Cr
EPS
8.33
PE Ratio
25.35
PB Ratio
3.44
Book Value
52.10
EBITDA
34.30
Dividend Yield
0.00 %
Industry
Chemicals
Return on Equity
13.55
Debt to Equity
0.87
Forecast For
Actual

Company News

View All News
Caret
positive
Mahamaya Lifesciences discloses interview on Dahej facility progress and FY26 financials. Revenue rose 24.5% to ₹328.87 crore, with net debt-to-equity improving to 0.74x.
neutral
Mahamaya Lifesciences held its 24th AGM on September 29, 2026. Key resolutions included re-designating Krishnamurthy Ganesan as Chairman and Prashant Krishnamurthy as MD.
neutral
Mahamaya Lifesciences schedules its 24th AGM for September 29, 2026. Key agenda items include the redesignation of the Chairman and Managing Director, alongside significant remuneration revisions for top executives.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
488.45
#1 41,233.45
17.58
#1 52,502.00
11.41
#1 2,220
58.52
27.92
2,118.20
32,136.93
27.67
7,024.40
-15.59
1,321
-38.95
30.62
417.30
20,829.35
35.45
3,385.00
3.56
543
20.44
29.52
3,492.00
15,693.78
20.81
5,770.00
3.16
689
15.39
29.06
723.90
6,531.06
#1 10.44
5,409.80
23.53
681
-38.38
39.98
198.06
3,851.65
31.33
2,631.40
6.54
164
-274.07
38.26
860.00
3,833.74
13.41
2,071.30
15.49
297
27.97
22.68
129.11
3,024.32
243.77
1,587.30
#1 27.74
5
60.00
26.76
222.13
2,880.34
105.24
538.30
19.68
18
#1 232.50
27.88
482.90
2,246.39
23.27
1,530.90
17.66
95
16.81
42.26
Growth Rate
Revenue Growth
23.50 %
Net Income Growth
28.91 %
Cash Flow Change
-6,765.12 %
ROE
-47.72 %
ROCE
-40.64 %
EBITDA Margin (Avg.)
6.90 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Revenue
0
118
Expenses
0
109
EBITDA
0
10
Operating Profit %
0 %
8 %
Depreciation
0
1
Interest
0
3
Profit Before Tax
0
7
Tax
0
2
Net Profit
0
5
EPS in ₹
0.00
3.04

Balance Sheet

Balance Sheet
2022
2023
2024
2025
2026
Total Assets
56
78
112
188
310
Fixed Assets
20
21
22
27
35
Capital Work in Progress
2
2
3
4
8
Investments
0
0
0
0
0
Other Assets
34
54
88
157
267
Total Equity & Liabilities
56
78
112
188
310
Current Liabilities
30
48
78
132
183
Non Current Liabilities
10
11
9
7
5
Total Equity
16
19
25
49
122
Reserve & Surplus
15
18
23
32
99
Share Capital
1
1
1
18
23

Cash Flow

Cash Flow
2022
2023
2024
2025
2026
Net Cash Flow
0
1
-0
1
35
Investing Activities
-3
-3
-2
-7
-16
Operating Activities
2
1
-23
-0
-30
Financing Activities
1
2
24
9
81

Share Holding

% Holding
Feb 2025
Oct 2025
Nov 2025
Mar 2026
Promoter
77.27 %
77.27 %
56.35 %
56.35 %
FIIs
0.00 %
0.00 %
6.39 %
4.77 %
DIIs
0.00 %
0.00 %
4.67 %
2.52 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
12.72 %
10.65 %
Others
22.73 %
22.73 %
19.88 %
25.71 %
No of Share Holders
18
18
1,034
584

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
02 Dec 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
02 Dec 2025 116.35 115.55
25 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
25 May 2026 172.00 170.00
29 Sept 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2026 200.10 177.80

Announcements

Publication Of Executive Interview In Agropages Magazine (2026 India Focus Issue)18 hrs ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20182 days ago
Announcement under Regulation 30 (LODR)-Change in Management10 days ago
Shareholder Meeting / Postal Ballot-Scrutinizers Report10 days ago
Shareholder Meeting / Postal Ballot-Outcome of AGM10 days ago
Closure of Trading WindowSep 28, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 08, 2026
Reg. 34 (1) Annual Report.Sep 07, 2026
Notice Of 24Th Annual General Meeting Of The CompanySep 07, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 07, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 25, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementAug 25, 2026
Appointment of Company Secretary and Compliance OfficerAug 25, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationAug 07, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 04, 2026
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerJul 30, 2026
Non-Applicability Of The Compliance On Corporate GovernanceJul 10, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 26, 2026
The Audited (Standalone & Consolidated) Financial Results Of The Company For The Half Year And Financial Year Ended 31.03.2026 Along With The Audit Reports ThereonMay 25, 2026
Board Meeting Outcome for Audited Financial Results (Standalone & Consolidated) For The Half Year And Year Ended On 31.03.2026May 25, 2026
Board Meeting Intimation for Prior Intimation Of The Board Meeting Pursuant To Regulation 29(1) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015May 20, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 05, 2026
Intimation Under Regulation 30 (LODR)_Certificate Of AppreciationMay 04, 2026
Announcement Under Regulation 30(LODR)-Receiving A Certification-"Great Place To Work"Apr 28, 2026
Non-Applicability Of The Compliance On Corporate Governance As Required Under Regulation 27(2) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 15, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2026
Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulation 2011Apr 03, 2026
Closure of Trading WindowMar 30, 2026
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 -Utilisation Of Unutilised IPO Proceeds In Subsequent Fiscal Years.Mar 10, 2026
Announcement Under Regulation 30 (LODR)-Intimation Of Withdrawn Of Participation In Virtual Conference On Monday 9" March 2026.Mar 09, 2026
Intimation Of Participation In Arihant Capital Bharat Connect Virtual Conference Rising Star 2026 On Monday 9Th March 2026.Mar 05, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management Personnel (SMP)Feb 17, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management Personnel (SMP)Feb 17, 2026
Announcement Under Regulation 30 - Receiving A Prestigious Award - Company Of The Year - Medium Scale At ICSCE 2026 DubaiJan 22, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 16, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 16, 2026
Submission Of Half Yearly Financial Results - September 2025Dec 02, 2025
Board Meeting Outcome for Submission Of Half Year Results - September 2025Dec 02, 2025
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial ResultsNov 26, 2025
Closure of Trading WindowNov 24, 2025
Listing of Equity Shares of Mahamaya Lifesciences LtdNov 18, 2025

Technical Indicators

RSI(14)
Neutral
45.03
ATR(14)
Volatile
7.36
STOCH(9,6)
Oversold
14.41
STOCH RSI(14)
Oversold
16.51
MACD(12,26)
Bearish
-0.59
ADX(14)
Weak Trend
14.83
UO
Bearish
32.59
ROC
Downtrend And Accelerating
-3.15
WillR
Oversold
-89.78